KUGLÍK, Petr,
Romana ZAORALOVÁ,
Hana FILKOVÁ, Henrieta GREŠLIKOVÁ,
Pavel NĚMEC, Alexandra OLTOVÁ,
Luděk POUR,
Zdeněk ADAM, M. KREJČÍ a Roman HÁJEK. Clinical implications of 13q14 and 17p13 deletion, t(4;14) and 1q21 amplification in patients with relapsed multiple myeloma treated by Thalidomide or Bortezomib (Velcade). In
Chromosome Research. Netherlands: Springer, 2007, s. 185-186. ISSN 0967-3849.